Logo image of HYPD

HYPERION DEFI INC (HYPD) Stock Fundamental Analysis

USA - NASDAQ:HYPD - US30234E2037 - Common Stock

5.01 USD
+0.04 (+0.8%)
Last: 11/14/2025, 8:00:01 PM
4.95 USD
-0.06 (-1.2%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to HYPD. HYPD was compared to 191 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HYPD have multiple concerns. HYPD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year HYPD has reported negative net income.
HYPD had a negative operating cash flow in the past year.
HYPD had negative earnings in each of the past 5 years.
HYPD had a negative operating cash flow in each of the past 5 years.
HYPD Yearly Net Income VS EBIT VS OCF VS FCFHYPD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

HYPD's Return On Assets of -708.22% is on the low side compared to the rest of the industry. HYPD is outperformed by 95.29% of its industry peers.
Industry RankSector Rank
ROA -708.22%
ROE N/A
ROIC N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HYPD Yearly ROA, ROE, ROICHYPD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

HYPD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYPD Yearly Profit, Operating, Gross MarginsHYPD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

0

2. Health

2.1 Basic Checks

HYPD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HYPD has more shares outstanding
Compared to 5 years ago, HYPD has more shares outstanding
HYPD has a worse debt/assets ratio than last year.
HYPD Yearly Shares OutstandingHYPD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
HYPD Yearly Total Debt VS Total AssetsHYPD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -63.88, we must say that HYPD is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of HYPD (-63.88) is worse than 93.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -63.88
ROIC/WACCN/A
WACC10.28%
HYPD Yearly LT Debt VS Equity VS FCFHYPD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

HYPD has a Current Ratio of 0.34. This is a bad value and indicates that HYPD is not financially healthy enough and could expect problems in meeting its short term obligations.
HYPD has a worse Current ratio (0.34) than 94.24% of its industry peers.
HYPD has a Quick Ratio of 0.34. This is a bad value and indicates that HYPD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HYPD (0.34) is worse than 93.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
HYPD Yearly Current Assets VS Current LiabilitesHYPD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

HYPD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.07%, which is quite impressive.
HYPD shows a strong growth in Revenue. In the last year, the Revenue has grown by 781.58%.
Measured over the past years, HYPD shows a very negative growth in Revenue. The Revenue has been decreasing by -84.00% on average per year.
EPS 1Y (TTM)43.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.14%
Revenue 1Y (TTM)781.58%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%200%

3.2 Future

Based on estimates for the next years, HYPD will show a very strong growth in Earnings Per Share. The EPS will grow by 20.36% on average per year.
HYPD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 250.09% yearly.
EPS Next Y33.51%
EPS Next 2Y21.63%
EPS Next 3Y20.36%
EPS Next 5YN/A
Revenue Next Year400.98%
Revenue Next 2Y356.17%
Revenue Next 3Y250.09%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HYPD Yearly Revenue VS EstimatesHYPD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2024 2025 2026 2027 10M 20M 30M
HYPD Yearly EPS VS EstimatesHYPD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50 -100

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HYPD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HYPD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYPD Price Earnings VS Forward Price EarningsHYPD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPD Per share dataHYPD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

A more expensive valuation may be justified as HYPD's earnings are expected to grow with 20.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.63%
EPS Next 3Y20.36%

0

5. Dividend

5.1 Amount

HYPD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HYPERION DEFI INC

NASDAQ:HYPD (11/14/2025, 8:00:01 PM)

After market: 4.95 -0.06 (-1.2%)

5.01

+0.04 (+0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)04-13 2026-04-13/amc
Inst Owners8.69%
Inst Owner ChangeN/A
Ins Owners30.36%
Ins Owner Change73.93%
Market Cap34.87M
Revenue(TTM)67.00K
Net Income(TTM)-42.38M
Analysts47.5
Price TargetN/A
Short Float %30.04%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.5%
Min EPS beat(2)5.64%
Max EPS beat(2)83.35%
EPS beat(4)3
Avg EPS beat(4)17.71%
Min EPS beat(4)-37.25%
Max EPS beat(4)83.35%
EPS beat(8)5
Avg EPS beat(8)6.62%
EPS beat(12)7
Avg EPS beat(12)7.27%
EPS beat(16)10
Avg EPS beat(16)16.18%
Revenue beat(2)0
Avg Revenue beat(2)-96.53%
Min Revenue beat(2)-96.75%
Max Revenue beat(2)-96.32%
Revenue beat(4)0
Avg Revenue beat(4)-97.42%
Min Revenue beat(4)-99.04%
Max Revenue beat(4)-96.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 520.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-34.16
EYN/A
EPS(NY)-26.52
Fwd EYN/A
FCF(TTM)-3.55
FCFYN/A
OCF(TTM)-3.54
OCFYN/A
SpS0.01
BVpS-1.4
TBVpS-1.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -708.22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -63.88
F-Score3
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)219.51%
Cap/Depr(5y)330.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.14%
EPS Next Y33.51%
EPS Next 2Y21.63%
EPS Next 3Y20.36%
EPS Next 5YN/A
Revenue 1Y (TTM)781.58%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%200%
Revenue Next Year400.98%
Revenue Next 2Y356.17%
Revenue Next 3Y250.09%
Revenue Next 5YN/A
EBIT growth 1Y-0.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-88.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.27%
OCF growth 3YN/A
OCF growth 5YN/A

HYPERION DEFI INC / HYPD FAQ

What is the fundamental rating for HYPD stock?

ChartMill assigns a fundamental rating of 1 / 10 to HYPD.


What is the valuation status for HYPD stock?

ChartMill assigns a valuation rating of 1 / 10 to HYPERION DEFI INC (HYPD). This can be considered as Overvalued.


What is the profitability of HYPD stock?

HYPERION DEFI INC (HYPD) has a profitability rating of 0 / 10.


What is the earnings growth outlook for HYPERION DEFI INC?

The Earnings per Share (EPS) of HYPERION DEFI INC (HYPD) is expected to grow by 33.51% in the next year.